A 65-year-old man presents to a gastroenterology clinic with a 4-week history of painless jaundice, significant pruritus, dark urine, and a 6-kg (13-lb) unintentional weight loss. His medical history is significant for type 2 diabetes mellitus diagnosed 6 months ago. He has a 40-pack-year smoking history. Vital signs are within normal limits. Physical examination reveals profound scleral icterus and a palpable, non-tender mass in the right upper quadrant of the abdomen. Laboratory studies demonstrate:
Total bilirubin: 14.2 mg/dL
Direct bilirubin: 11.5 mg/dL
Alkaline phosphatase: 720 U/L
Aspartate aminotransferase (AST): 85 U/L
Alanine aminotransferase (ALT): 92 U/L
A contrast-enhanced multiphasic computed tomography (CT) scan of the abdomen is obtained. The radiologist's report describes a 3.5-cm hypoattenuating mass in the head of the pancreas. There is marked dilation of both the common bile duct and the main pancreatic duct. Furthermore, the mass encases the superior mesenteric artery (SMA) for approximately 270 degrees of its circumference and causes short-segment occlusion of the superior mesenteric vein (SMV). No hepatic or pulmonary lesions are identified.
Based on the interpretation of these imaging results, which of the following is the most accurate conclusion regarding this patient's diagnosis and management?
- The imaging demonstrates locally advanced, unresectable disease due to arterial encasement, making systemic therapy or palliation the most appropriate approach.Cevap
- BAn MRI of the abdomen with MRCP must be ordered to confirm the extent of vascular involvement before determining surgical candidacy.
- CThe combination of a pancreatic mass and new-onset diabetes confirms a diagnosis of autoimmune pancreatitis, warranting a diagnostic trial of corticosteroids.
- DAn open surgical biopsy must be performed immediately to obtain a definitive tissue diagnosis before proceeding with any endoscopic or palliative interventions.
- EThe profound direct hyperbilirubinemia and elevated alkaline phosphatase indicate a primary autoimmune liver etiology, meaning the pancreatic mass is likely an incidental adenoma.